The latest price target for Mesa Laboratories (NASDAQ:MLAB) was reported by Evercore ISI Group on July 2, 2024. The analyst firm set a price target for $106.00 expecting MLAB to rise to within 12 months (a possible 11.39% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Mesa Laboratories (NASDAQ:MLAB) was provided by Evercore ISI Group, and Mesa Laboratories maintained their outperform rating.

The last upgrade for Mesa Laboratories Inc happened on January 4, 2024 when Evercore ISI Group raised their price target to $125. Evercore ISI Group previously had an in-line for Mesa Laboratories Inc.

There is no last downgrade for Mesa Laboratories.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mesa Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mesa Laboratories was filed on July 2, 2024 so you should expect the next rating to be made available sometime around July 2, 2025.

While ratings are subjective and will change, the latest Mesa Laboratories (MLAB) rating was a maintained with a price target of $120.00 to $106.00. The current price Mesa Laboratories (MLAB) is trading at is $95.16, which is out of the analyst’s predicted range.